How Chinese Manufacturers Enter the Thai FDA Market
Thailand is a key destination for Chinese manufacturers expanding into Southeast Asia, particularly in regulated sectors such as medical devices, dietary supplements, and cosmetics.
However, entering the Thai FDA system requires a different regulatory approach compared to China or domestic Chinese standards.
Key Challenges for Chinese Manufacturers
Chinese companies typically face the following issues:
- Lack of approvals in recognized reference countries
- Technical documentation not aligned with ASEAN standards
- Differences in product classification under Thai FDA
- Absence of a local legal entity in Thailand
These factors often result in delays or unsuccessful submissions if not properly addressed.
Regulatory Strategy for Thailand
A successful market entry usually requires:
- Classification assessment under Thai FDA rules
- Restructuring of technical documentation
- Alignment with ASEAN regulatory frameworks
- Identification of a compliant local license holder
In many cases, documentation prepared for the Chinese market must be significantly adapted before submission.
Real Case Example
A Shenzhen-based manufacturer of Class IV implantable bioabsorbable devices entered Thailand without prior approvals in reference countries using our license holding service.
Through dossier restructuring, classification review, and local regulatory support, the product was successfully registered under Thai FDA.
Conclusion
Thai FDA registration for Chinese manufacturers is feasible, but requires a structured regulatory strategy and local expertise. Companies approaching the process with China-based documentation only typically face significant delays or rejection.
If your company is planning to enter the Thai market and requires regulatory support, contact Siam Trade Development for an initial assessment.
